LONGENY launches truGut360, a breakthrough gut microbiome test set 

LONGENY, a precision-health startup advancing personalised preventive care, has introduced truGut360, a next-generation gut microbiome test designed to uncover the root biological imbalances fuelling today’s chronic health crisis. Developed with scientific support from Austria-based MyBioma, truGut360 brings one of the most comprehensive microbiome analysis solutions available to Indian consumers.

For years, individuals experiencing persistent bloating, acidity, fatigue, PCOS symptoms, thyroid irregularities, autoimmune issues, weight fluctuations, or unexplained inflammation have had little clarity on underlying causes. truGut360 changes this by analysing microbial diversity, inflammation markers, metabolic pathways, immune–gut interactions, digestion patterns, and early indicators of long-term disease risk.

As digestive and metabolic disorders surge one in three Indians now reports weekly digestive discomfort, and over 135 million live with metabolic disease. The demand for deeper, root-cause-driven diagnostics has never been greater.

Why the Gut Microbiome Matters More Than Ever: Scientific evidence shows that up to 70% of the immune system and nearly 90% of metabolic activity are regulated by the gut microbiome. Global research now links gut dysbiosis to a wide spectrum of chronic issues including obesity, PCOS, diabetes, depression, hormonal imbalance, autoimmune disorders, chronic fatigue, and accelerated ageing.

truGut360 converts this complex science into a practical at-home tool bringing lab-grade insight, once restricted to cutting-edge research facilities, directly to individuals through a simple sample and a digitally delivered precision-health report.

A New Framework for Personalised, Root-Cause–Based Preventive Care: Unlike generic wellness tests, truGut360 uses advanced sequencing technology and an AI-driven precision-health framework to deliver personalised, clinically grounded recommendations. It provides insights across multiple areas, including personalised nutrition guidance, digestion and metabolic efficiency, immunity and inflammation reduction, hormonal balance, and overall energy, mood, and long-term vitality. The objective is not just to detect imbalance, but to provide a clear, evidence-backed path to reverse it.

“India is in the middle of a health crisis that most people don’t recognise. Gut dysfunction is driving everything from low energy to hormonal instability to severe metabolic disease, yet it remains invisible in routine check-ups. truGut360 makes the invisible visible. When individuals understand what’s happening inside their gut, they finally get the clarity and direction needed to take control of their health today, not years later”, said Anil K.C, Founder & CEO, LONGENY

“The gut microbiome is a central regulator of long-term health. With truGut360, people across India can now access advanced microbial insights that were once limited to specialised research centres. This represents an important shift toward personalised, proactive health management”, said Dr. Nikolaus Gasche, Co-founder & Managing Director, MyBioma

As chronic metabolic and lifestyle disorders rise, and as younger populations adopt proactive health behaviours, truGut360 arrives at a defining moment for India’s healthcare evolution. LONGENY, already recognised for its work in precision diagnostics and root-cause–based health optimisation, believes the test will become a foundational tool for individuals looking to improve digestion, stabilise metabolism, support hormonal health, and enhance their overall healthspan.